| (INR) | Jun 2017 | Y/Y change |
|---|---|---|
| Revenue | 106.51M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MERCURYLAB.BO returned -9.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -6.0% |
| 1 year | -9.7% |
| 5 years | +15.6% |
| 10 years | +55.5% |
| All-time high | ₹1,239.20 (Jan 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in MERCURYLAB.BO would be worth today ›No. Mercury Laboratories Limited has not paid a dividend in the past 12 months.
Mercury Laboratories Limited is part of the Healthcare sector.
Mercury Laboratories Limited has a market cap of 937.20M INR, based on the latest quote.
